Human papillomavirus type 6 (HPV-6) DNA is the predominant HPV type found in condyloma acuminata: it is rarely found in carcinomas. We have previously reported cloning and characterizing an HPV-6 from a vulvar condyloma (HPV6-W50) and an HPV-6 from a vulvar carcinoma (HPV6-T70). The E5, E6 and E7 proteins encoded by the two genomes were identical, however, the two genomes differed in the long control region (LCR). Cloning of the entire LCR into the enhancerless plasmid pSVEcat showed that the two LCRs had comparable enhancer activity. Since the major differences between the two LCRs resided in the 5' end of the LCR, upstream of the L1 polyadenylation signal, we subcloned the two LCRs to analyse more closely their effect on cat gene expression. The data indicated that LCR subclones of the two genomes had comparable chloramphenicol acetyltransferase (CAT) activity. A negative regulatory region was detectable when the test plasmids were transfected into HeLa and C33A cells and in primary keratinocytes. A decrease in CAT activity was also detected when the SV40 early promoter was replaced with the putative HPV-6 E6 promoter. The negative regulatory region functioned in a position-and orientation-independent manner, thus fulfilling the definition of a silencer.
Introduction
Human papillomaviruses (HPVs) are small DNA viruses that cause a variety of epithelial proliferations. Over 70 HPV types have been identified, based originally on DNA hybridization (Coggin & zur Hausen, 1979 ) and more recently on sequence analysis (Van Ranst et al., 1994) . Some HPV types are predominantly associated with benign lesions (e.g. HPV-6) while others are more commonly found in malignancies of the lower genital tract (e.g. HPV-16). The genomes can be divided into coding sequences and the long control region (LCR) which lies between the end of the major capsid protein L 1 and the start of the early protein E6. Expression of the viral genes is influenced by the LCR which contains cis elements that can be trans-activated or repressed by inducible or constitutive cellular factors or by the viral early protein E2 (Cripe et al., 1987; Wu & Mounts, 1988; Auborn et al., 1989; Chong et al., 1990; Reh & Pfister, 1990; Cripe et al., 1990; Auborn & Steinberg, 1991; Chong et al., 1991 ; Mack & Laimins, 1991 ; Ishiji et al., 1992; Bauknecht et aL, 1992 ; Thierry e t al., 1992; Cuthill * Author for correspondence. Fax +1 317 274 4090. e-mail aroman @indycms.iupui.edu Dollard et al., 1993; Kyo et al., 1993; Kyo et al., 1994; May et al., 1994) . We have recently cloned and characterized an HPV-6 from a benign lesion, HPV6-W50, and one from a malignant lesion, HPV6-T70, in an effort to understand the relationship of the viral genomes to the type of lesion from which they were isolated (Kasher & Roman, 1988; Farr et al., 1991) . The two viruses are identical in the genes implicated in oncogenesis (E5, E6 and E7), but differ in sequences in the 5' half of the LCR, upstream of the L1 polyadenylation signal. Differences in the LCR could alter the level of early gene expression and thereby influence the outcome of infection. For example, HPV-6 genomes have been characterized which carry insertions or duplications in the LCR (Rando et al., 1986; Kulke et al., 1989) . These LCRs have been shown to have greater enhancer activity than an LCR without the alteration. When the entire LCRs of HPV6-W50 and HPV6-T70 were analysed for their influence on expression from a downstream promoter they were found to act similarly. Both acted as enhancers in epithelial cells (HeLa cells) and neither had enhancer activity in fibroblasts (Vero cells) (Farr et al., 1991) . However, it was possible that the effect of the sequence differences was masked in the background of the entire LCR. Therefore, we undertook an analysis of the activity of the subfragments of the LCR containing the sequence differences. Two points became clear from this investigation. First, the fragments behaved similarly to one another. Second, rather than enhancing the activity of a downstream promoter, the fragments negatively regulated both the homologous HPV-6 E6 and a heterologous SV40 early promoter in a position-and orientation-independent manner, thus fulfilling the definition of a silencer (Brand et al., 1985) . Silencer activity was detected in HeLa cells, C33A cells and primary human keratinocytes.
Methods
Plasmids. The plasmids pW50acat and pT70acat were described previously (Farr et al., 1991) and contain the LCRs of the HPV6-W50 and HPV6-T70 genomes (GenBank accession numbers L22693 and L22694, respectively) inserted into the NdeI site of the enhancerless plasmid pSVEcat . pW50acat and pT70acat were used to generate the subclones of the LCRs (Fig. 1) . The plasmids were digested with either MluI or Narl and the resulting recessed 3' ends filled-in using the Klenow fragment of DNA polymerase (Boehringer Mannheim) (Sambrook et al., 1989) . The DNA was then digested with NdeI and the fragments were gel purified. NdeI linkers were added to the fragments to allow insertion of the fragments into the NdeI site of pSVEcat. The contents of the plasmids containing the LCR subfragments are summarized in Table 1 . Plasmids pP12aScat, pHEcat, pW12aHcat and pP12aHcat were constructed to test position-and promoter-independence of the region 1 + 2 subfragment of the HPV6-W50 LCR (Fig. 1, Table 1 ). To construct pP12aScat, pWl2acat was cleaved with NdeI to release region 1 + 2. The ends of the fragment were filled in with T4 polymerase and ligated to pSVEcat, which had been cleaved with PstI and the ends filled-in with T4 polymerase. To construct pHEcat, the putative HPV6-W50 E6 promoter was amplified using PCR and contained nt 7871 to 98. Amplifying primers were constructed such that the 5' end of the fragment contained an XbaI site and the 3' end contained a HindIII site. pSVEcat was cleaved with XbaI and HindIII to remove the SV40 early promoter. The HPV-6 E6 promoter was ligated to the remaining large fragment of pSVEcat. pW12aHcat was similarly constructed by replacing the SV40 early promoter in pW12acat with the HPV-6 E6 promoter, pP12aHcat was constructed by inserting region 1 + 2 into the PstI site of pHEcat in an analogous fashion to that described for the construction of pP12aScat. pHEluc was constructed by removing the cat sequence (encoding chloramphenicol acetyltransferase; CAT) from pHEcat with HindIII and HpaI and replacing it with the HindIII-SmaI fragment encoding luciferase (LUC) from pRSVluc, pP12aHluc was constructed by removing the cat sequence from pP 12aHcat with HindIII and Sinai and replacing it with the HindII~SmaI lue fragment from pRSVluc. Plasmids were purified either over two CsCl-ethidium bromide gradients, by the PEG procedure (Sambrook et al., 1989) , or by using Qiagen columns. To verify that all plasmids contained the authentic sequence the plasmid preparations were sequenced. To construct pGEMSVE6, pGEM3Zf+ was cleaved with Hincll and EcoRI as was pSVEcat, and the fragment carrying the promoter and 5'-coding sequence of cat was cloned into the cleaved pGEM vector, pSV2N-cat-A13 was a kind gift from Lubomir Turek and Tom Hangen (Ushikai et al., 1994) . It contains a 13 bp deletion at the HindIII site, located between the promoter and the cat gene, allowing its transcript to be probed with the same probe as used for the pSVEcat-based plasmids. The plasmid pRSVflgal contains the Rous sarcoma virus (RSV) long terminal repeat (LTR) driving the fl-galactosidase (flgal) gene (Thierry & Yaniv, 1987 
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Region 1 Region 2 Region 3 Fig. 1 . Subcloning scheme for HPV6-W50 and HPV6-T70 LCRs. The designations of the different subfragments are given above and the region designations are given below the LCRs. Sites common to both LCRs are shown on the line designating nucleotide numbers. The L1 stop codon is located at nt 7288; the late polyadenylation signal is located at nt 7407; the ATG for E6 is located at nt 102. The numbering system is that of HPV-6b (Schwarz et al., 1983) . Nuclear factor binding sites C/EBP, AP1, CK, E2, SphI, AP3, GRE, NFI and NFIII were identified by computer search (Farr et al., 1991) . O, ACTGT sequences (an arrow indicates the ACTGT sequence previously suggested to be important in silencer activity; Wu & Mounts, 1988) . (a) 94 bp insertion relative to HPV-6b at nt 7350; (b) 24 bp insertion at nt 7323; (c) 58 bp insertion at nt 7350; (d) 49 bp deletion at nt 7350 (Kasher & Roman, 1988; Farr et al., 1991) . Note that 57 nt of the 58 bp insertion (c) in HPV6-T70 are identical to the first 58 bp of the 94 bp insertion (a) of HPV6-W50. * The lower-case a indicates the insertion is in the sense orientation; the antisense orientation.
t HPV-6b nt numbering system (Schwarz et al., 1983) .
the lower-case b indicates serum and 100 m~-gentamicin and transfected as previously described (Farr et al., 1991) . C33A cells (ATCC) were grown in DMEM supplemented with 10 % fetal calf serum and gentamicin. The cells were plated at 4x 106 and transfected the following day with 1 lag test plasmid, 0.1 lag pRSVluc and 8"9 lag salmon sperm DNA using the calcium phosphate coprecipitation method (Graham & van der Eb, 1973) . Human foreskin keratinocyte cultures were initiated from newborn human foreskins obtained from routine circumcisions following the procedure of Rheinwald (1980) . The resulting single-cell suspensions were pooled, plated on a feeder layer of mitomycin-Ctreated 3T3 or J2 cells (Rheinwald, 1980) and maintained in DMEM containing 10% fetal bovine serum, growth supplements (Fuchs & Green, 1981) and antibiotics (Farr et al., 1987) . Third passage keratinocytes were transfected with 15 I~g test plasmid, 5 lag pRSVflgal and 15 lag of salmon sperm DNA using the polybrene technique (Kawai & Nishizawa, 1984) as modified by Farr et aL (1987) .
Assays for CAT, flgal and LUC. Cells were harvested at 48 h posttransfection, the cell pellet resuspended in 100 lal 0.25 M-Tris (pH 7-8), and the cells subjected to three cycles of freeze-thaw (Gorman et al., 1982) . The CAT assay was performed by incubating the extract with acetyl-CoA and [l~C]chloramphenicol and separating the products by thin-layer chromatography (Farr e t al., 1991) . Alternatively, the extract was incubated with butyryl-CoA and radiolabelled chloramphenicol, and after incubation the butyrylated chloramphenicol was quantified in a scintillation counter after extraction with xylenes (Seed & Sheen, 1988) . The reactions were incubated for 1~ h for the HeLa and C33A cells and for 4-6 h for the keratinocytes. Assays for flgal were performed as previously described (Farr et al., 1991) or using the Galacto-Light kit (Tropix, Bedford, Mass., USA). Assays for LUC were performed using the Luciferase Assay System (Promega).
RNase protection assay. RNA was extracted from C33A cells 24 h after transfection with the test plasmid and pSV2N-cat-A13 using TRIREAGENT (Molecular Research Center, Inc., Cincinnati, Ohio, USA). RNA (20 ~tg) was hybridized with the 463 nt [~-a2p]UTPlabelled riboprobe synthesized from pGEMSVE6 following cleavage with HincII. Riboprobe synthesis and RNase protection assays were conducted using the Ambion MAXIscript and RPA II kit, respectively.
Results

The HPV6-WSO and HPV6-TTO LCR subclones have similar activities in HeLa cells
To look for differences between the LCRs that might not be seen in the context of the entire LCRs, subclones were constructed to separate the region of insertions and deletions from the region of single base pair changes. In the original cloning of the LCRs, DpnI (nt 7151) and NdeI (nt 235) had been used. Within the LCR, two different restriction sites, MluI at nt 7454 and NarI at nt 7691, were used for subcloning the fragments into pSVEcat to minimize the chance of destroying an important binding site in the subclones (Fig. 1) . Each subclone and pRSVflgal were cotransfected into HeLa cells to determine if there were differences in enhancer activity between pHPV6-W50 and pHPV6-T70. The subclones containing the 3' region of the LCR, either region 2 + 3 or region 3 alone, contain only single base pair changes (Farr et al., 1991) . These subclones all showed enhancer activity in HeLa cells, but no consistent difference was seen between the subclones of HPV6-W50 and HPV6-T70 (Table 2 ). The subclones containing the 5' region of the LCR (region 1 + 2 or region 1 alone) contained the insertions and deletions of the LCRs (Fig.  1) . No difference was seen in the activity of these subclones from HPV6-W50 versus HPV6-T70, but no enhancer activity (2-fold or greater than pSVEcat) was seen ( Table 3 ). The CAT activities of the test plasmids were 50% or less than that of the parent plasmid, pSVEcat, suggesting the presence of sequences which were negatively regulating expression. The effect was * CAT activity from cells transfected with pSVEcat or the test plasmids was standardized to the activity of the internal control. The activity of the test plasmids was subsequently normalized to the parental pSVEcat plasmid with the value of pSVEcat set to 1. Results are presented as the mean-+ SD; each experiment was conducted in duplicate.
NO, Not done. Table 2 . ND, Not done.
orientation-independent since it was observed with constructs in the sense as well as antisense configuration. This result prompted us to investigate the possibility of silencer activity in the 5' half of the HPV-6 LCR, concentrating on HPV6-W50 since no consistent difference in activity was detected between the subfragments of HPV6-W50 and HPV6-T70.
Position-and promoter-independence of the negative regulatory region
Experiments were undertaken to determine whether the negative regulatory activity of region 1 + 2 was positionindependent and whether region 1+2 affected the homologous HPV-6 E6 early promoter, in addition to the heterologous SV40 early promoter. In the previous experiments the LCRs and subfragrnents were inserted 232 bp upstream of the SV40 early promoter. New recombinants were constructed with region 1 + 2 inserted proximal to the promoter. In addition, the SV40 early promoter was replaced with the putative HPV-6 E6 promoter. A position-independent decrease in CAT activity was seen in the context of the SV40 promoter (Fig. 2) . A decrease in CAT activity was also seen when the cat gene was driven by the HPV-6 E6 promoter and region 1 +2 was inserted either adjacent to or 232 bp upstream of the promoter (Fig. 2) . Therefore, the negative regulatory activity of the 5' region of the LCR was position-and promoter-independent. Since the level of activity of the HPV-6 E6 promoter was less than that of the SV40 early promoter (data not shown), but the outcome with both promoters was the same, experiments were continued using the SV40 early promoter.
The negative regulatory region is active in C33A cells
HeLa cells contain a portion of the HPV-18 genome and express E6 and E7 (Schwarz et al., 1985) . (Fig. 3) . To control for transfection efficiency the cells were cotransfected with pSV2N-cat-A13; RNA from this construct yields a 260 nt RNase-resistant fragment. The signals on the autoradiogram were quantified by densitometry. Following correction for differences in signal from the internal control and normalization to pSVEcat, the relative cat message was 0.4 for pP12aScat and 2.0 for pW50cat. The data substantiate the hypothesis that the negative regulation is at the level of transcription.
liiii!iiii~ii~ii~ii~i!iiiiiilHE I cat I 0-13 + 0.05 I P Fig. 2 . Effect of region 1 + 2 on cat gene expression. Region 1 + 2 was inserted either 232 bp upstream (NdeI site) or adjacent (PstI site) to the SV40 or HPV early promoter. HeLa cells were cotransfected with these plasmids and pRSVflgal and the outcome determined following normalization first to flgal activity and subsequently to the CAT activity produced by the parental plasmids pSVEcat or pHEcat. Values indicated are the means_+sD for three to nine experiments, each conducted in duplicate. the ability of the 5' region of the LCR to act as a negative regulatory region in the absence of HPV gene products, a limited number of experiments were conducted in C33A cells which do not contain any HPV DNA. In four experiments, each conducted in duplicate, region 1 +2 (present in pP12aScat) consistently caused a decrease in CAT activity (0.35 ___ 0"11 relative to pSVEcat) while the entire LCR (present in pW50acat) continued to display enhancer activity (4.73 _ 1.95).
Negative regulation occurs at the promoter
To confirm that transcription was correctly initiated from the SV40 early promoter, and that the negative regulation was reflected in quantitative differences in the
Transfection of keratinocytes with HPV6-W50 LCR and subclones
To determine whether silencer and enhancer activities could be seen in primary keratinocytes the subclones were analysed following transfection into these primary cells. Only the entire HPV6-W50 LCR and subclones were used since no difference in activity between the HPV6-W50 LCR and the HPV6-T70 LCR had been seen in keratinocytes (data not shown) and no difference between the subclones was seen in HeLa cells. The subclones containing region 2+3 or region 3 alone showed enhancer activity (Table 2) as was seen in the HeLa transfections (Table 2 ). The subclones which contained region 1 +2 showed silencer activity in the context of the plasmid pSVEcat (Table 3) . In contrast to the HeLa cell experiments, no silencer activity was seen with the subclone containing region 1 alone.
Experiments were next conducted to address whether region 1 +2 was also able to negatively regulate its homologous promoter, HPV-6 E6. To increase the sensitivity of the assay the cat gene was replaced with the luc gene. Keratinocyte cultures were initiated in E medium (Wu et al., 1982) and transferred into SFM (Gibco/BRL) prior to transfection with 4 ~tg test plasmid, 0"5 ~tg pRSVflgal and 7"5 ~tg pUC19 DNA by the modified polybrene technique of Dollard et al. (1993) . In four experiments, each conducted in duplicate, introduction of region 1 + 2 proximal to the E6 promoter (pP12aHluc) consistently resulted in a decrease in LUC activity (0"38_0.11 relative to pHEluc).
Titration of input plasmids
To determine whether failure to detect silencing activity with region 1 in keratinocytes was due to an excess of transfected DNA relative to a putative cellular silencer A. Farr and others protein(s), the amount of transfected DNA was decreased from 15 pg/plate (Table 3 ) to either 10 pg or 2-5 pg/plate. In these experiments, greater silencer activity was seen with the lower input DNA (Table 4 ). This effect was not an artifact of lower overall CAT activity, since experiment 3 showed high CAT activity with the entire LCR and silencer activity with the region 1 subclone. Experiment 3 also indicates that the negative regulation is orientation-independent.
Discussion
HPV6-W50 and HPV6-T70 were cloned from a benign wart and an invasive carcinoma, respectively (Kasher & Roman, 1988; Farr et al., 1991) . Sequence analysis of the LCRs, and the E5, E6 and E7 open reading frames indicated that only the LCR sequences differed (Farr et al., 1991) . We have previously shown that the intact LCRs have similar enhancer activity in HeLa cells. We report here that comparison of a given subfragment derived from each LCR indicates that they also have similar activities: HPV6-W50 and HPV6-T70 region 2+3 and region 3 alone have comparable enhancing activity while region 1 and region 1 + 2 fail to enhance cat expression from the SV40 early promoter. Further, the data establish that both HPV6-W50 and HPV6-T70 region 1 + 2 fulfil the criteria for a silencer and do so not only in cervical carcinoma cell lines but also in primary keratinocytes. These results extend the report of Wu & Mounts (1988) that insertion of region 1 + 2 of HPV-6g in the sense orientation proximal to the SV40 early promoter resulted in a decrease in CAT activity in HeLa and C33A cells. As noted above, region 2 + 3 as well as region 3 alone of both HPV6-W50 and HPV6-T70 enhance expression. In contrast, Wu & Mounts found that HPV-6g region 3 alone but not region 2 + 3 increased expression in HeLa cells. Since for HPV-6g only a 136 bp sequence present in duplicate in region 3 and a 5 bp sequence in region 1 have been reported it is not currently possible to postulate the reason for the differences in activity of region 2 + 3. In region 3 of HPV6-W50 and HPV6-T70 each genome has a single copy identical to HPV-6g in 130 out of 136 bp; all differences reside within the first 8 nt of the 136 bp sequence. Interestingly, HPV-6e region 3, which has only a single copy of the 136 bp sequence, decreases, rather than increases downstream expression.
Since both HPV6-T70 and HPV6-W50 contain a silencer region, either the relevant region is one they share (within region 1 + 2) or the 24 bp sequence present only in region 1 of HPV6-T70 compensates for the 85 bp sequence present only in region 1 of HPV6-W50 (Farr et al., 1991) . HPV-6g region 1 as well as region 1+2 decreased cat expression in HeLa cells (Wu & Mounts, 1988) . In contrast, region 1 alone of HPV-6e did not decrease gene expression. The only difference between HPV-6e and HPV-6g within region t + 2 resides in region 1 : HPV-6g contains an ACTGT sequence where HPV-6e contains a TAGTGTTA sequence. Wu & Mounts therefore suggested that the ACTGT sequence at nt 7331 was important for silencer activity. Consistent with this hypothesis, both HPV6-T70 and HPV6-W50 contain the ACTGT sequence. However, it should be noted that the sequence AAGTGTTG, comparable to that of HPV-6e, was found to have silencing activity when present in the bovine papillomavirus type 4 genome (Jackson & Campo, 1991) . Thus the context of the sequence may be important. Other putative cis elements within region 1 + 2 for which there are precedents for involvement in negative regulation in other systems include the C/EBP, AP1 and GRE sites (Hay et al., 1989; Lucibello et al., 1990; Lopez-Cabrera et al., 1990 ). An alternating purine-thymidine-rich sequence and/or short repeats located 5' to the late polyadenylation signal, at nt 7407 (Farr et al., 1991) , may also play a role in negative regulation (Santoro et al., 1984; Yu & Manley, 1986) . We are currently defining the specific sequence(s) necessary and sufficient for silencer activity.
Since the regulatory activities were comparable between HPV6-W50 and HPV6-T70, the HPV6-W50 subclones were analysed in more detail. While a decrease in CAT activity was detected in HeLa cells whether region 1 or region 1 + 2 was present, in keratinocytes the silencer activity was initially only detected in region 1 + 2. Whether there is a substantive difference between these two cell types remains to be determined, Even in HeLa cells, region 1 was not always sufficient to detect silencer activity. In addition, the transfection protocols for the cell line and primary culture were different. There is, however, a precedent for a difference in the behaviour of an LCR region in a cervical carcinoma cell line and primary keratinocytes: Dollard et al. (1993) found that whereas the HPV-11 cis element CEIl acted as an enhancer and overcame repression mediated by the viral E2 protein in C33A cells, it had no effect in primary keratinocytes.
The data suggest that there may be two separable activities, one in region 1 and a second in region 2 or at the junction between regions 1 and 2. In HeLa cells, C33A cells and keratinocytes, region 1 +2 acted as a silencer. Region 1 alone also showed silencer activity but less reproducibly. There are three possible interpretations of these results: (a) there are different silencer elements in region 1 and region 2, (b) the element in region 1 and region 2 is the same but its context (surrounding elements) is different, and (c) interactions with the two elements (whether the same or different) are additive.
The expression programme of the papillomaviruses is dependent upon the state of differentiation of the keratinocyte (Stoler et al., 1989; Iftner et al., 1992) . The presence of a silencer provides a means by which viral gene expression could be controlled during differentiation: changes in interactions at this site could relieve repression and allow greater expression of the genome in the differentiating keratinocyte. The repression described here is not total, nor is it expected to be since some viral gene expression is seen in basal cells. The implication of the data presented in Table 4 is that the activity responsible for silencing may be titratable, such that the activity is titrated out at a high input of the test plasmid (15 ~tg). In natural infection the silencer could be effective in basal cells where the viral copy number is low, but no longer effective when the viral genome is amplified in the differentiating keratinocyte. Alternatively the cognate protein(s) or cofactors may not be expressed or may become inactivated, or a transactivator(s) may be expressed or activated, during differentiation thus relieving the repression of transcription.
